Liquid Biopsy 2.0 is moving beyond cancer. Discover how circulating biomarkers, cell-free DNA, RNA, and extracellular vesicles could transform disease detection, monitoring, and the future of precision medicine.
Explore how CRISPR gene editing is transforming precision medicine by enabling targeted DNA modifications for inherited diseases, cancer treatment, and regenerative medicine while addressing ethical challenges.
Discover how targeted therapies are transforming precision oncology by matching cancer treatments to genetic mutations, enabling more personalized and effective care.
Discover how spatial transcriptomics maps gene expression within tissues, revealing cellular interactions and advancing precision medicine.
Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies.
Multi-omics medicine integrates genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of disease biology. By analyzing multiple molecular layers together, it enables earlier detection, more accurate diagnosis, and more personalized treatment strategies in precision healthcare.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.
